Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

The journal welcomes submissions in all of these fields.

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies
Coordinating editor
  • Trevor W. Robbins,
  • Christelle Baunez,
  • Patricia H. Janak
Principal editor
  • Harriet de Wit,
  • Valerie H Curran,
  • A. Leslie Morrow,
  • Kenji Hashimoto,
  • Oliver Howes,
  • Stan B. Floresco,
  • Deepak D'Souza
Publishing model
Hybrid. Open Choice – What is this?
Impact
Impact factor: 3.424 (2018)
Five year impact factor: 3.300 (2018)
Speed
Submission to first decision: 52 days
Acceptance to publication: 15 days
Usage
Downloads: 1,025,632 (2018)

Articles

Subscribe

Subscription
$199.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2019

Advertisement

About this journal

Electronic ISSN
1432-2072
Print ISSN
0033-3158
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. Chemical Abstracts Service (CAS)
  5. Current Contents/ Life Sciences
  6. EBSCO Academic Search
  7. EBSCO Advanced Placement Source
  8. EBSCO Biomedical Reference Collection
  9. EBSCO CINAHL
  10. EBSCO Discovery Service
  11. EBSCO Psychology & Behavioral Sciences Collection
  12. EBSCO Rehabilitation & Sports Medicine Source
  13. EBSCO SPORTDiscus
  14. EBSCO STM Source
  15. EMBASE
  16. ERIH PLUS
  17. Gale
  18. Gale Academic OneFile
  19. Google Scholar
  20. Highbeam
  21. IFIS Publishing
  22. Institute of Scientific and Technical Information of China
  23. Japanese Science and Technology Agency (JST)
  24. Journal Citation Reports/Science Edition
  25. Medline
  26. Meta
  27. Naver
  28. OCLC WorldCat Discovery Service
  29. Pathway Studio
  30. ProQuest Agricultural & Environmental Science Database
  31. ProQuest Animal Behavior Abstracts
  32. ProQuest Biological Science Database
  33. ProQuest Central
  34. ProQuest Chemoreception Abstracts
  35. ProQuest Environmental Science
  36. ProQuest Health & Medical Collection
  37. ProQuest Health Research Premium Collection
  38. ProQuest Medical Database
  39. ProQuest Natural Science Collection
  40. ProQuest Neurosciences Abstracts
  41. ProQuest Nursing & Allied Health Database
  42. ProQuest Pharma Collection
  43. ProQuest Psychology Database
  44. ProQuest SciTech Premium Collection
  45. ProQuest Toxicology Abstracts
  46. ProQuest-ExLibris Primo
  47. ProQuest-ExLibris Summon
  48. PsycINFO
  49. Reaxys
  50. SCImago
  51. SCOPUS
  52. Science Citation Index
  53. Science Citation Index Expanded (SciSearch)
Copyright information

Rights and permissions

Springer Nature policies

© Springer-Verlag GmbH Germany, part of Springer Nature